Paradigm Biocapital Advisors LP Olema Pharmaceuticals, Inc. Transaction History
Paradigm Biocapital Advisors LP
- $2.14 Billion
- Q2 2025
A detailed history of Paradigm Biocapital Advisors LP transactions in Olema Pharmaceuticals, Inc. stock. As of the latest transaction made, Paradigm Biocapital Advisors LP holds 6,764,172 shares of OLMA stock, worth $72.1 Million. This represents 1.35% of its overall portfolio holdings.
Number of Shares
6,764,172
Previous 6,741,172
0.34%
Holding current value
$72.1 Million
Previous $25.3 Million
13.69%
% of portfolio
1.35%
Previous 1.3%
Shares
8 transactions
Others Institutions Holding OLMA
# of Institutions
126Shares Held
68.8MCall Options Held
0Put Options Held
31.4K-
Bain Capital Life Sciences Investors, LLC Boston, MA6.84MShares$73 Million8.75% of portfolio
-
Bvf Inc San Francisco, CA5.3MShares$56.5 Million0.89% of portfolio
-
Black Rock Inc. New York, NY4MShares$42.6 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA3.51MShares$37.4 Million0.08% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.44MShares$36.7 Million0.52% of portfolio
About Olema Pharmaceuticals, Inc.
- Ticker OLMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,419,600
- Market Cap $431M
- Description
- Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...